The effect of diltiazem on calcinosis in a patient with the CREST syndrome.

We describe a patient with a 23-year history of progressive calcinosis and features of the CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, telangiectasias) who was treated with diltiazem, 240 mg/day, for 5 years. No clinical exacerbation of calcinosis occurred during treatment. Radiographs showed no new lesions, and there was reduction in the size of the existing lesions. Bone scans revealed a progressive decrease in the uptake of the radionuclide by soft tissue foci. We propose that diltiazem may stop the progression of calcinosis by reducing the cellular calcium influx in affected tissues.

[1]  R. Touraine,et al.  Failure of warfarin in treatment of calcinosis universalis. , 1988, The American journal of medicine.

[2]  J. Griffin,et al.  Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy , 1988, Neurology.

[3]  N. A. Patrone.  Treatment of calcinosis universalis with low-dose warfarin. , 1987, The American journal of medicine.

[4]  W. McCartney,et al.  Treatment of calcinosis universalis with low-dose warfarin. , 1987, The American journal of medicine.

[5]  M. Goligorsky,et al.  Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. , 1985, Kidney international.

[6]  B. Brambati,et al.  Calcium and magnesium content in fetuses at risk and prenecrotic Duchenne muscular dystrophy , 1984, Neurology.

[7]  J. J. Stewart,et al.  Cutaneous calcinosis of scleroderma. Successful treatment with intralesional adrenal steroids. , 1982, Archives of dermatology.

[8]  T. Bertorini,et al.  The effects of diltiazem in dystrophic hamsters , 1982, Muscle & nerve.

[9]  J. Williams,et al.  Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris. , 1981, The Journal of clinical investigation.

[10]  T. Haavik,et al.  Calcinosis in dermatomyositis treated with probenecid. , 1981, Scandinavian journal of rheumatology.

[11]  A. Masi,et al.  The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma). , 1979, Archives of internal medicine.

[12]  G. Bole,et al.  Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis. , 1978, Annals of internal medicine.

[13]  J. Felsenstein,et al.  Calcinosis cutis circumscripta. Treatment with an intralesional corticosteroid. , 1978, Archives of dermatology.

[14]  C. Pearson,et al.  Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. , 1974, The New England journal of medicine.

[15]  C. Dent,et al.  Treatment of Calcinosis Circumscripta with Probenecid , 1972, British medical journal.

[16]  R. Barmada,et al.  Diphosphonate treatment of calcinosis universalis. , 1971, The New England journal of medicine.

[17]  J. Vaughan,et al.  CALCINOSIS UNIVERSALIS COMPLICATING DERMATOMYOSITIS. ITS TREATMENT WITH NA2 EDTA. REPORT OF TWO CASES IN CHILDREN. , 1964, Arthritis and rheumatism.